Cargando…

Reprogramming of Amino Acid Metabolism in Pancreatic Cancer: Recent Advances and Therapeutic Strategies

Pancreatic ductal adenocarcinoma (PDAC) is one of the most fatal malignancies with an extremely poor prognosis. Energy metabolism reprogramming, an emerging hallmark of cancer, has been implicated in the tumorigenesis and development of pancreatic cancer. In addition to well-elaborated enhanced glyc...

Descripción completa

Detalles Bibliográficos
Autores principales:	Xu, Ruiyuan, Yang, Jinshou, Ren, Bo, Wang, Huanyu, Yang, Gang, Chen, Yuan, You, Lei, Zhao, Yupei
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2020
Materias:	Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7550743/ https://www.ncbi.nlm.nih.gov/pubmed/33117704 http://dx.doi.org/10.3389/fonc.2020.572722

Ejemplares similares

High-resolution Hi-C maps highlight multiscale 3D epigenome reprogramming during pancreatic cancer metastasis
por: Ren, Bo, et al.
Publicado: (2021)

Metabolism of pancreatic cancer: paving the way to better anticancer strategies
por: Qin, Cheng, et al.
Publicado: (2020)

The role of histone methylation in the development of digestive cancers: a potential direction for cancer management
por: Chen, Yuan, et al.
Publicado: (2020)

Epigenetic reprogramming-induced guanidinoacetic acid synthesis promotes pancreatic cancer metastasis and transcription-activating histone modifications
por: Yang, Jinshou, et al.
Publicado: (2023)

Early screening and diagnosis strategies of pancreatic cancer: a comprehensive review
por: Yang, Jinshou, et al.
Publicado: (2021)

Construction of a prognostic model with histone modification-related genes and identification of potential drugs in pancreatic cancer
por: Chen, Yuan, et al.
Publicado: (2021)

Glutathione S-Transferase Mu-3 Predicts a Better Prognosis and Inhibits Malignant Behavior and Glycolysis in Pancreatic Cancer
por: Wang, Shunda, et al.
Publicado: (2020)

Comprehensive Analysis of Autophagy-Associated lncRNAs Reveal Potential Prognostic Prediction in Pancreatic Cancer
por: Chen, Guangyu, et al.
Publicado: (2021)

Recent advances microRNAs and metabolic reprogramming in colorectal cancer research
por: Xiong, Bin, et al.
Publicado: (2023)

Cholesterol Metabolic Reprogramming in Cancer and Its Pharmacological Modulation as Therapeutic Strategy
por: Giacomini, Isabella, et al.
Publicado: (2021)

Tumor microenvironment participates in metastasis of pancreatic cancer
por: Ren, Bo, et al.
Publicado: (2018)

Amino acid metabolic reprogramming in tumor metastatic colonization
por: Wang, Zihao, et al.
Publicado: (2023)

Metabolic Reprogramming of Non-Hodgkin's B-Cell Lymphomas and Potential Therapeutic Strategies
por: Ricci, Jean-Ehrland, et al.
Publicado: (2018)

Recent Advances in Cancer Plasticity: Cellular Mechanisms, Surveillance Strategies, and Therapeutic Optimization
por: Fanelli, Giuseppe Nicolò, et al.
Publicado: (2020)

Serine-associated one-carbon metabolic reprogramming: a new anti-cancer therapeutic strategy
por: Zhang, Jing, et al.
Publicado: (2023)

Editorial: Metabolic reprogramming for acquiring therapeutic resistance in glioblastoma
por: Hsu, Tsung-I
Publicado: (2023)

Recent advances in the diagnostic and therapeutic roles of microRNAs in colorectal cancer progression and metastasis
por: Liang, Chen, et al.
Publicado: (2022)

Reprogramming lipid metabolism as potential strategy for hematological malignancy therapy
por: Zhang, Leqiang, et al.
Publicado: (2022)

Epigenetic reprogramming in pancreatic premalignancy and clinical implications
por: Zhang, Wei, et al.
Publicado: (2023)

Role of the microbiome in occurrence, development and treatment of pancreatic cancer
por: Wang, Yicheng, et al.
Publicado: (2019)

Glucometabolic reprogramming: From trigger to therapeutic target in hepatocellular carcinoma
por: Xia, Haoming, et al.
Publicado: (2022)

Knockout of ENO1 leads to metabolism reprogramming and tumor retardation in pancreatic cancer
por: Song, Qingru, et al.
Publicado: (2023)

Editorial: Advances in the Pathogenesis and Therapeutic Strategies for Nasopharyngeal Carcinoma
por: Yang, Kai-Bin, et al.
Publicado: (2021)

Bone Invasive Meningioma: Recent Advances and Therapeutic Perspectives
por: Takase, Hajime, et al.
Publicado: (2022)

The Role and Therapeutic Perspectives of Sirtuin 3 in Cancer Metabolism Reprogramming, Metastasis, and Chemoresistance
por: Zhao, QingYi, et al.
Publicado: (2022)

Recent Advances in Targetable Therapeutics in Metastatic Non-Squamous NSCLC
por: Bansal, Pranshu, et al.
Publicado: (2016)

Macrophages and Metabolic Reprograming in the Tumor Microenvironment
por: Liu, Jin, et al.
Publicado: (2022)

GSTM3 Function and Polymorphism in Cancer: Emerging but Promising
por: Wang, Shunda, et al.
Publicado: (2020)

Identification of the Roles of a Stemness Index Based on mRNA Expression in the Prognosis and Metabolic Reprograming of Pancreatic Ductal Adenocarcinoma
por: Tang, Rong, et al.
Publicado: (2021)

Editorial: The Microenvironment in Pancreatic Cancer and Therapeutic Strategies Targeting Microenvironment
por: Duan, Wanxing, et al.
Publicado: (2022)

Cellular and Molecular Mechanisms of Pristimerin in Cancer Therapy: Recent Advances
por: Chen, Run-Ze, et al.
Publicado: (2021)

Advanced diagnostic and therapeutic strategies in nanotechnology for lung cancer
por: Duan, Yujuan, et al.
Publicado: (2022)

MicroRNA-27a (miR-27a) in Solid Tumors: A Review Based on Mechanisms and Clinical Observations
por: Zhang, Jingcheng, et al.
Publicado: (2019)

Identification and characterization of interferon-γ signaling-based personalized heterogeneity and therapeutic strategies in patients with pancreatic cancer
por: Chen, Xu, et al.
Publicado: (2023)

Single-cell analysis reveals cellular reprogramming in advanced colon cancer following FOLFOX-bevacizumab treatment
por: Yang, Meiling, et al.
Publicado: (2023)

Metabolic Reprogramming in Thyroid Carcinoma
por: Coelho, Raquel Guimaraes, et al.
Publicado: (2018)

A commentary on ‘Inflammatory biomarkers and nanotechnology: new insights in pancreatic cancer early detection’
por: Xu, Ruiyuan, et al.
Publicado: (2023)

Malignant ascites in pancreatic cancer: Pathophysiology, diagnosis, molecular characterization, and therapeutic strategies
por: Han, Margaret Y., et al.
Publicado: (2023)

A novel therapeutic strategy of combined camrelizumab and apatinib for the treatment of advanced hepatocellular carcinoma
por: Yang, Qing, et al.
Publicado: (2023)

Metabolic Reprogramming in Gastric Cancer: Trojan Horse Effect
por: Bin, Yu-Ling, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_9l47if3dve3rv3no6e0m6nokbu